Researchers have uncovered the complex cellular mechanisms of Ebola virus, which could help explain its severe toll on humans and identify potential pathways to treatment and prevention.
Study reveals how our immune system reacts to COVID-19 variants
New research into how our immune system responds to COVID-19 reveals that those infected by early variants in 2020 produced sustained antibodies, but these antibodies are not as effective against contemporary variants of the virus.
Scientists closing in on map of the mammalian immune system
Using artificial intelligence, scientists have identified thousands of genetic mutations likely to affect the immune system in mice.
Engineered cells successfully treat cardiovascular and pulmonary disease
Scientists have shown that gene-edited cellular therapeutics can be used to successfully treat cardiovascular and pulmonary diseases, potentially paving the way for developing less expensive cellular therapies to treat diseases for which there are curr…
New cancer findings can give wider access to immunotherapy
Researchers have shown how pharmacological activation of the protein p53 boosts the immune response against tumors. The results can be of significance to the development of new combination therapies that will give more cancer patients access to immunot…
Structures discovered in brain cancer patients can help fight tumors
Researchers have discovered lymph node-like structures close to the tumor in brain cancer patients, where immune cells can be activated to attack the tumor. They also found that immunotherapy enhanced the formation of these structures in a mouse model….
Being clean and hygienic need not impair childhood immunity
The theory that modern society is too clean, leading to defective immune systems in children, should be swept under the rug, according to a new study.
Cancer: Immunotherapies without side effects?
Immunotherapy has revolutionized the field of cancer treatment. However, inflammatory reactions in healthy tissues frequently trigger side effects that can be serious. Scientists have succeeded in establishing the differences between deleterious immune…
Study ties milder COVID-19 symptoms to prior run-ins with other coronaviruses
In COVID-19 patients whose symptoms were mild, researchers found that they were more likely than sicker patients to have signs of prior infection by similar, less virulent coronaviruses.
Study finds 94 percent of patients with cancer respond well to COVID-19 vaccines
More than 9 of 10 patients with cancer showed good immune response to the COVID-19 mRNA vaccines after receiving both doses, but subsets of high-risk patients did not, according to a new study.